CHKP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CHKP is not a good buy right now for a beginner long-term investor with $50,000-$100,000 who wants to act now. The stock has weak technical momentum, multiple analyst downgrades, and a softer growth outlook, while hedge funds are selling. Although the options data is mildly constructive and Q1 revenue/EPS still grew, the overall setup does not support an immediate buy. Best view: hold off for now.
Technically, CHKP is in a bearish setup. MACD histogram is below zero and still negative, moving averages are bearish with SMA_200 > SMA_20 > SMA_5, and price is trading near the first support level at 114.844 after closing at 114.55. RSI_6 around 29.943 indicates weakness but not a strong reversal confirmation. The stock trend model is mixed to weak, with a possible short-term bounce but negative weekly expectation. Overall, trend remains bearish and momentum is not supportive for a fresh long-term entry.
["Q1 2026 revenue rose 4.80% YoY to 668.4M.", "EPS increased 5.85% YoY to 1.81.", "Net income was slightly higher year over year.", "Options positioning is mildly constructive with put-call ratios below 1.", "Insiders are neutral, with no major negative insider trading trend."]
["BofA downgraded CHKP to Neutral and cut its target sharply to $120 from $260.", "Several other analysts also reduced targets, reflecting weaker growth confidence.", "News points to limited revenue reacceleration and pressure in the firewall business, which is about 52% of revenue.", "Revenue growth expectations are slowing materially into 2026.", "Gross margin declined year over year.", "Hedge funds have been selling, with selling up 135.15% over the last quarter.", "Technical trend is bearish and price is near support rather than in an uptrend.", "No AI Stock Picker or SwingMax signal today."]
In Q1 2026, Check Point showed modest growth: revenue increased to 668.4M, up 4.80% YoY, EPS rose 5.85% YoY to 1.81, and net income was up slightly by 0.37% YoY. The weak spot was profitability quality, as gross margin fell to 85.38%, down 1.65% YoY. This is still a solid business financially, but the latest quarter did not show the growth acceleration investors want.
Recent analyst trend is clearly negative. Multiple firms cut price targets after a disappointing Q1, with BofA downgrading to Neutral and slashing its target from $260 to $120. BMO, Citi, Goldman Sachs, Morgan Stanley, Scotiabank, Baird, and Roth all lowered targets, with several keeping neutral/equal-weight views. Wall Street’s pros view is that the company remains high quality and still profitable, but the cons dominate right now: weak demand metrics, slowing growth, and execution issues in the firewall business. That makes the stock look more like a wait-and-see name than an immediate buy.
